CT-Based Radiomics Can Predict the Efficacy of Anlotinib in Advanced Non-Small-Cell Lung Cancer

Anlotinib is a small-molecule RTK inhibitor that has achieved certain results in further-line treatment, but many patients do not respond to this drug and lack effective methods for identification. Although radiomics has been widely used in lung cancer, very few studies have been conducted in the fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jingyu, Wang, Chuhuai, Qu, Weinuo, Liu, Fangfang, Zhou, Zilin, Li, Jiali, Hu, Qiongjie, Xie, Qingguo, Wang, Jinlin, Chu, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807313/
https://www.ncbi.nlm.nih.gov/pubmed/36600966
http://dx.doi.org/10.1155/2022/4182540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807313/
https://www.ncbi.nlm.nih.gov/pubmed/36600966
http://dx.doi.org/10.1155/2022/4182540

Ejemplares similares